斯巴敏与传统解痉剂治疗肠易激综合征的疗效对比  

The Spasmomen and traditions solve curative effect contrast for curing the IBS

作　　者：杨世昇 

机构地区：[1]厦门市第一医院药学部,福建厦门361022

出　　处：《中国现代应用药学》2006年第S1期678-679,共2页Chinese Journal of Modern Applied Pharmacy

摘　　要：目的对照传统解痉剂观察斯巴敏治疗肠易激综合征(IBS)的疗效和安全性。方法选择本院消化内科符合IBS诊断的病人67例,随机分成二组,分别予以斯巴敏和654-2治疗,疗程均为2周,采取问卷调查、临床IBS症状疗效观察等方式。结果治疗2周后,斯巴敏组和654-2组的总有效率分别为76.2%和56%,两者比较有明显差异。结论斯巴敏不良反应小,是治疗IBS的一个有效的药物。OBJECTIVE To check tradition spasmolytic and observe curative effect and safety of Spasmomen,Otilonium bromide for IBS treatment by contrast.METHODS To select 67 patients diagnosed IBS in the digest department of the hospital,divide them into 2 groups randomly,separately be treated by Spasmomen,Otilonium bromide and 654-2 for 2 weeks period of treatment each other and then have paper investagation and IBS clinic indexes observation etc.RESULTS After 2 weeks treatment,the total effective rates of Spasmomen,O...

关 键 词：斯巴敏 肠易激综合征 

分 类 号：R574.4[医药卫生—消化系统]